Friday, August 8, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

Elaine Mendonca by Elaine Mendonca
January 23, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As we enter the year 2024, analysts have been actively sharing their assessments of Inari Medical (NASDAQ:NARI), offering a wide range of perspectives from bullish to bearish. Let’s take a closer look at their recent ratings and how sentiments have evolved over the past 30 days, comparing them to previous months:

– Bullish: In the last 30 days, one analyst has expressed a bullish outlook, with no previous bullish ratings in the preceding months.
– Somewhat Bullish: Another analyst has shown a somewhat bullish sentiment in the past 30 days, with no previous ratings of this nature in the previous months.
– Indifferent: Two analysts have remained indifferent, with no significant changes in their assessments. However, one analyst has shifted from an indifferent stance to a slightly bearish outlook, while another analyst has moved from an indifferent position to a somewhat bullish sentiment.
– Somewhat Bearish: Currently, there are no analysts expressing a somewhat bearish outlook.
– Bearish: Similarly, there are no analysts holding a bearish view on Inari Medical.

Turning our attention to the 12-month price targets, analysts have presented an average target of $73.0 for Inari Medical. The highest estimate stands at $85.00, while the lowest estimate is $65.00. Notably, the current average target has increased by 1.86% from the previous average of $71.67.

In terms of recent analyst actions, we have Mike Matson from Needham announcing a Buy rating with a $72.00 price target. Richard Newitter from Truist Securities has raised the Hold rating to $70.00 from $65.00. On the other hand, Adam Maeder from Piper Sandler has lowered the Overweight rating to $85.00 from $90.00.

According to TipRanks, Inari Medical holds a consensus rating of Strong Buy, based on 6 Buy ratings, 1 Hold rating, and 0 Sell ratings. The average price target stands at $80.00.

Over the past year, the consensus rating for Inari Medical stock has been Moderate Buy, based on the assessments of 5 analysts.

Overall, the average analyst rating for Inari Medical stock is “Buy,” indicating their belief that this stock is likely to outperform the market in the next twelve months.

NARI Stock Shows Modest Gains with Slight Upward Momentum

On January 23, 2024, NARI stock showed modest gains as it traded in the middle of its 52-week range and below its 200-day simple moving average. The stock had a price increase of $0.06 since the market last closed, representing a rise of 0.10%. NARI shares closed at $57.55 and rose by an additional $0.76 in pre-market trading.

NARI’s performance on this day indicates a slight upward momentum, albeit a modest one. Trading within the middle of its 52-week range suggests that the stock has not experienced any significant price swings in the past year. This stability may be seen as a positive sign for investors who prefer less volatile stocks.

Furthermore, NARI’s price being below its 200-day simple moving average indicates that the stock has been trading at a lower level compared to its long-term average price. This could potentially be a concern for investors as it suggests a bearish trend over the long term. However, it is important to note that the 200-day moving average is just one indicator among many, and investors should consider other factors before making any investment decisions.

The price increase of $0.06 since the market last closed may seem small, but it still represents a positive movement for NARI stock. This rise of 0.10% shows that there is some buying interest in the stock, which could be attributed to positive news or market sentiment surrounding the company.

In pre-market trading, NARI stock rose by an additional $0.76. Pre-market trading refers to the buying and selling of stocks before the regular market trading hours. While pre-market trading can provide some insight into market sentiment, it is important to note that these trades may not accurately reflect the stock’s performance once the market opens. Therefore, investors should exercise caution when interpreting pre-market movements.

Overall, NARI stock’s performance on January 23, 2024, indicates a modest upward momentum, with a slight price increase since the market last closed. However, the stock remains below its 200-day simple moving average, suggesting a bearish trend over the long term. Investors should carefully evaluate all available information and consider their own investment goals and risk tolerance before making any decisions regarding NARI stock.

NARI Stock Performance Analysis: Total Revenue, Net Income, and EPS in January 2024

NARI Stock Performances on January 23, 2024: A Closer Look

On January 23, 2024, NARI stock experienced significant changes in its financial performance. By analyzing the data provided by CNN Money, we can gain insights into the company’s total revenue, net income, and earnings per share (EPS) for the past year and the third quarter of 2023.

Starting with the total revenue, NARI reported a total revenue of $383.47 million for the past year. This figure represents a 38.45% increase compared to the previous year’s revenue. Furthermore, the company’s total revenue for the third quarter of 2023 stood at $126.37 million, reflecting a 6.19% increase since the previous quarter.

The positive growth in total revenue indicates that NARI has been successful in generating more sales and expanding its business operations.

Moving on to net income, NARI reported a net loss of $29.27 million for the past year. This figure represents a significant decrease of 397.43% compared to the previous year’s net income. However, the company managed to turn things around in the third quarter of 2023, reporting a net income of $3.16 million. This represents a substantial increase of 51.65% since the previous quarter.

The drastic decrease in net income for the past year may raise concerns among investors and stakeholders. However, the significant improvement in the third quarter indicates that NARI has taken steps to address its financial challenges and improve its profitability.

Lastly, let’s examine the earnings per share (EPS) figures. NARI reported an EPS of -$0.55 for the past year, indicating a decrease of 412.94% compared to the previous year. However, in the third quarter of 2023, the company reported an EPS of $0.05, reflecting an increase of 51.69% since the previous quarter.

The increase in EPS for the third quarter suggests that NARI has made progress in improving its profitability on a per-share basis.

In conclusion, NARI stock experienced notable changes in its financial performance on January 23, 2024. The company witnessed a significant increase in total revenue, both on a yearly and quarterly basis. Although NARI reported a net loss for the past year, it managed to turn things around in the third quarter, reporting a positive net income. Additionally, the company’s EPS showed improvement in the third quarter, indicating progress in enhancing profitability on a per-share basis. Investors and stakeholders should closely monitor NARI’s future financial reports to assess the sustainability of these positive trends.

Tags: NARI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Sanofi Acquires Inhibrx Incs INBRX101 in 22 Billion Deal

Pharmaceutical Stock Market Today

FDA Approves Special Protocol Assessment for Outlook Therapeutics NORSE EIGHT Trial

Partnership Announcement Camber Energy Inc and BOX 03 International SA Collaborate for Sustainable Waste Management

Recommended

ALB stock news

Allspring Global Investments Increases Stake in Automotive Parts Company, Douglas Dynamics Inc.

2 years ago
Technology Robotics Markets and money

Exela Technologies Inc and XBP Europe Launch Reaktrai Revolutionizing Cybersecurity and Data Management with AI

2 years ago

Positive Outlook and Increased Price Target for Corteva

2 years ago
Alternative Energy Markets and money (1)

Ecopetrols Commitment to Thorough Evaluation and Reliable Results for Arauca 8 Well

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Lucid Group Stock: Turbulence Amid Policy Shifts and Uber Deal

Walt Disney Stock: Marvel Woes Offset by NFL Deal

Fresenius Stock: Mixed Q2 Results Amid Margin Pressures

Beiersdorf Stock: Nivea’s Glow Fades as Forecasts Dim

ABN Amro Stock: Profit Dip Amid Strong Capital Moves

Vonovia Stock: Strong Recovery Fuels Optimism

Trending

Snap Stock
Stocks

Snap Stock: Turmoil Amid Advertising Woes

by Dieter Jaworski
August 6, 2025
0

Snap Inc.'s stock has become a battleground for Wall Street analysts following disappointing Q2 results, with price...

DHL Stock

DHL Stock: Rollercoaster Ride Amid Strong Earnings

August 6, 2025
Klöckner Stock

Klöckner Stock: Turnaround Amid Market Volatility

August 6, 2025
Lucid Group Stock

Lucid Group Stock: Turbulence Amid Policy Shifts and Uber Deal

August 6, 2025
Walt Disney Stock

Walt Disney Stock: Marvel Woes Offset by NFL Deal

August 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Eckert & Ziegler Stock: Strong Earnings, Weak Market Reaction August 8, 2025
  • Intel Stock: CEO Under Fire as Shares Plunge August 8, 2025
  • Bechtle Stock: Mixed Q2 Results Amid Margin Pressures August 8, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com